(Q54478097)

30 May 2018

title

Inhibitory effect of antisense oligonucleotide targeting TIMP-2 on immune-induced liver fibrosis. (English)

1 reference

30 May 2018

author name string

Qing-He Nie

1

1 reference

30 May 2018

Chuan-Long Zhu

2

1 reference

30 May 2018

Ya-Fei Zhang

3

1 reference

30 May 2018

Jie Yang

4

1 reference

30 May 2018

Jiu-Cong Zhang

5

1 reference

30 May 2018

Ren-Tao Gao

6

1 reference

30 May 2018

publication date

11 June 2009

1 reference

30 May 2018

Digestive Diseases and Sciences

published in

1 reference

30 May 2018

volume

55

1 reference

30 May 2018

issue

5

1 reference

30 May 2018

page(s)

1286-1295

1 reference

30 May 2018

https://scigraph.springernature.com/pub.10.1007/s10620-009-0858-5

exact match

0 references

cites work

Correlation between TIMP-1 expression and liver fibrosis in two rat liver fibrosis models

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10620-009-0858-5

Induction of hepatitis C virus-specific cytotoxic T and B cell responses by dendritic cells expressing a modified antigen targeting receptor

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10620-009-0858-5

Gene modulation for treating liver fibrosis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10620-009-0858-5

Inhibiting effect of antisense oligonucleotides phosphorthioate on gene expression of TIMP-1 in rat liver fibrosis.

21 January 2018

1 reference

12 December 2020

Fibrosis accelerates the development of enzyme-altered lesions in the rat liver

1 reference

12 December 2020

Antisense approaches to immune modulation for transplant and autoimmune diseases

1 reference

12 December 2020

Conditional tetracycline-regulated expression of TGF-β1 in liver of transgenic mice leads to reversible intermediary fibrosis

1 reference

12 December 2020

A potent and specific morpholino antisense inhibitor of hepatitis C translation in mice

1 reference

12 December 2020

Management of chronic hepatitis B

1 reference

12 December 2020

Sense and antisense: therapeutic potential of oligonucleotides and interference RNA in asthma and allergic disorders

1 reference

12 December 2020

Novel antisense oligonucleotides targeting TGF-beta inhibit in vivo scarring and improve surgical outcome.

1 reference

12 December 2020

Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion.

1 reference

12 December 2020

Antifibrotic effects of tetrandrine on hepatic stellate cells and rats with liver fibrosis

1 reference

12 December 2020

Antisense, RNAi, and gene silencing strategies for therapy: mission possible or impossible?

1 reference

12 December 2020

Therapeutic potential of RNA interference

1 reference

12 December 2020

Modified synthetic siRNA targeting tissue inhibitor of metalloproteinase-2 inhibits hepatic fibrogenesis in rats

1 reference

12 December 2020

Expression of MMPs and TIMPs in liver fibrosis - a systematic review with special emphasis on anti-fibrotic strategies

1 reference

12 December 2020

Protein engineering of the tissue inhibitor of metalloproteinase 1 (TIMP-1) inhibitory domain. In search of selective matrix metalloproteinase inhibitors

1 reference

12 December 2020

1 reference

12 December 2020

Antifibrotic therapy in chronic liver disease

1 reference

12 December 2020

Cloning of the rat tissue inhibitor of metalloproteinases type 2 (TIMP-2) gene: analysis of its expression in normal and transformed thyroid cells.

1 reference

12 December 2020

Update on chronic hepatitis C.

1 reference

12 December 2020

Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: comparison with PIIINP and hyaluronic acid.

1 reference

12 December 2020

Liver fibrosis -- from bench to bedside

1 reference

12 December 2020

Tissue remodelling in liver diseases

1 reference

12 December 2020

Plasma levels of matrix metalloproteinase-2 (MMP-2) and tissue inhibitors of metalloproteinases -1 and -2 (TIMP-1 and TIMP-2) as noninvasive markers of liver disease in chronic hepatitis C: comparison using ROC analysis

1 reference

12 December 2020

Hepatic stellate cell behavior during resolution of liver injury

1 reference

12 December 2020

Liver extracellular matrix in health and disease

1 reference

12 December 2020

[Animals with liver fibrosis induced by albumin immunization]

1 reference

12 December 2020

Clinical evaluation of serum levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases as predictors of progressive fibrosis in postoperative biliary atresia patients

1 reference

12 December 2020

10.1007/S10620-009-0858-5

Identifiers

DOI

1 reference

30 May 2018

1 reference

30 May 2018